Great West Life Assurance CO Amicus Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 74,554 shares of FOLD stock, worth $782,071. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,554
Previous 85,104
12.4%
Holding current value
$782,071
Previous $843,000
5.34%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding FOLD
# of Institutions
298Shares Held
321MCall Options Held
355KPut Options Held
456K-
Vanguard Group Inc Valley Forge, PA28.8MShares$302 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$294 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$287 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$256 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$221 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.94B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...